Valvular heart disease can lead to loss of physical function, quality of life, and longevity, rapidly contributing to global cardiovascular morbidity and mortality. Its global epidemiology varies substantially, with a predominance of functional and degenerative diseases in high-income countries, whereas rheumatic heart disease is predominant in low- and middle-income countries. Therefore, staying up-to-date with diagnostic and management-related advances is essential for cardiovascular surgeons. Join the renowned Cardiovascular Thoracic Surgeon Dr.
Yogesh Belapurkar in our exclusive session on “Valvular Heart Disease ” on 12 th February 2024, 11:00 AM IST onwards. Suggested for you ACC/AHA Guidelines on Valvular Heart Disease and Case Discussions ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no…
